News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Photo of Devika Das from X
Jun 28, 2024, 12:37

Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors

Devika Das, Medical Director at Parexel, recently shared on LinkedIn:   .

“It definitely takes a village. With the advent of check point inhibitors there is a whole new Pandora’s box of toxicities and we need all our teams involved in patient care, engaged and educated on early recognition!
Check out our latest publication in the MMI series!”

Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors

Read further.
Source: Devika Das/LinkedIn

cancer cancer treatment Check point Inhibitors Devika Das early recognition immunotherapy Medical Research MMI series OncoDaily Oncology parexel patient care publication team involvement toxicities
Special Coverage
Blog
Feb 10, 2025, 18:28
Narjust Florez: Thank you ASCO - never imagined this to happen when still in my 30s
Blog
Feb 10, 2025, 18:24
Stephanie Graff: Thank you, ASCO, for the beautiful award
Science
Feb 10, 2025, 18:20
Leela Morená: Xenotransplantation of a porcine kidney for end-stage kidney disease
Blog
Feb 10, 2025, 18:17
New 2025-2027 committee nominations are now open - IASLC
Blog
Feb 10, 2025, 18:10
Rasu Shrestha: Proud of what we, as a team across Advocate Health, have already accomplished
Blog
Feb 10, 2025, 17:17
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Blog
Feb 10, 2025, 16:55
Did you know that some cancer treatments cause cardiotoxicity? - Oncogene Cancer Research
Blog
Feb 10, 2025, 16:49
AAMC Statement on Drastic Cuts to NIH-Funded Research
Science
Feb 10, 2025, 16:45
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Insight
Feb 10, 2025, 16:08
Drew Moghanaki: A common-sense interpretation of clinical trial data
Blog
Feb 10, 2025, 15:56
Herbert Loong: Join us for the inaugural ESMO TAT Asia 2025 meeting
Blog
Feb 10, 2025, 15:44
Monica Bertagnolli: At times of systemic stress, it is the next generations who stand to lose the most